Is Sanjivani Paranteral a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Sanjivani Paranteral Ltd is a average quality company .

Is Sanjivani Paranteral undervalued or overvalued?

The key valuation ratios of Sanjivani Paranteral Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Sanjivani Paranteral share price return in the past 10 years?

Sanjivani Paranteral Ltd share price has appreciated 30.6% annually (CAGR) over the past ten years.

Is Sanjivani Paranteral a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sanjivani Paranteral Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

Sanjivani Paranteral Ltd - Stock Valuation and Financial Performance

Name: Sanjivani Paranteral
Brand: Sanjivani Paranteral

BSE: 531569 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Sanjivani Paranteral Share Price

₹230.40 5.55 2.47%
as on 17-Jun'25 16:59

10 Year X-Ray of Sanjivani Paranteral:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	5.7%	-7.3%	-33%	-227.3%	0%	-266%	266.4%	0%	0%	55.3%	-
Value Creation Index ⓘ	-0.6	-1.5	NA	NA	NA	NA	18.0	NA	NA	3.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	133	115	32.7	18	25.1	16.4	25.1	30.6	35.5	54.4	70
Sales YoY Gr.	-	-13.2%	-71.7%	-45%	39.7%	-34.8%	53.4%	22%	15.9%	53.3%	-
Adj EPS ⓘ	-4.2	-25.2	-46	-90	-3.7	-3.2	1.5	4.7	4.2	5	6.7
YoY Gr.	-	NA	NA	NA	NA	NA	NA	214.8%	-10.9%	20.3%	-
BVPS (₹) ⓘ	54.5	29.7	-14.8	-89.6	-80	-82.9	-52.8	-7.6	-3.1	22.1	31.6
Adj Net Profit ⓘ	-2.5	-14.9	-27.2	-53.1	-2.2	-1.9	1.3	4.7	4.2	5.9	8
Cash Flow from Ops. ⓘ	-1.2	0.5	9.6	3.1	2.5	-0.2	0.6	8.5	4.7	-10.7	-
Debt/CF from Ops. ⓘ	-47.6	139.7	6.3	15.8	19.4	-280.1	79	0.7	0.5	-0.1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-9.5%	16.7%	29.4%	53.3%
Adj EPS ⓘ	NA	NA	50%	20.3%
BVPSⓘ	-9.5%	NA	NA	NA
Share Price	30.6%	98.4%	72%	31.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	-7.4	-60	-618.2	172.5	4.4	3.9	-2.7	-17.9	-78.4	47.3	25
Op. Profit Mgn % ⓘ	4	-4.8	-70.4	-289.8	-7	-3.4	8.5	13.9	14.8	14.7	14.8
Net Profit Mgn % ⓘ	-1.9	-12.9	-83.1	-295.5	-8.7	-11.3	5.1	15.3	11.8	10.8	11.6
Debt to Equity ⓘ	1.8	3.6	-6.9	-0.9	-1	-1	-1	-0.8	-0.8	0	0.1
Working Cap Days ⓘ	263	284	722	649	171	179	133	128	121	118	90
Cash Conv. Cycle ⓘ	197	221	567	420	-105	-169	-112	-90	-82	-3	52

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 25.00%

Sales growth is growing at healthy rate in last 3 years 29.42%

Net Profit is growing at healthy rate in last 3 years 50.01%

Sales growth is good in last 4 quarters at 29.38%

No data to display

Latest Financials - Sanjivani Paranteral Ltd.

	Standalone	Consolidated
TTM EPS (₹)	6.7	-
TTM Sales (₹ Cr.)	70.1	-
BVPS (₹.) ⓘ	31.6	-
Reserves (₹ Cr.) ⓘ	26	-
P/BV ⓘ	7.11	-
PE ⓘ	33.53	-

From the Market
52 Week Low / High (₹)	171.50 / 396.95
All Time Low / High (₹)	1.76 / 396.95
Market Cap (₹ Cr.)	272
Equity (₹ Cr.)	12.1
Face Value (₹)	10
Industry PE ⓘ	41.7

Management X-Ray of Sanjivani Paranteral:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Sanjivani Paranteral

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

No data found!

Key Ratios of Sanjivani Paranteral

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	133	115	33	18	25	16	25	31	35	54
Operating Expenses ⓘ	128	121	56	70	27	17	23	26	30	46
Manufacturing Costs	1	2	2	2	1	1	2	3	3	4
Material Costs	120	113	28	25	15	9	15	12	19	28
Employee Cost	3	3	3	3	2	2	2	3	3	4
Other Costs ⓘ	3	4	23	40	8	4	4	8	5	10
Operating Profit ⓘ	5	-6	-23	-52	-2	-1	2	4	5	8
Operating Profit Margin (%)	4.0%	-4.8%	-71.2%	-290.0%	-7.0%	-3.4%	8.5%	13.9%	14.8%	14.7%
Other Income ⓘ	1	1	3	0	1	0	0	2	1	1
Interest ⓘ	8	9	5	0	0	1	0	0	0	0
Depreciation ⓘ	1	1	1	1	1	1	1	1	1	1
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	-3	-15	-26	-53	-2	-2	1	5	5	8
Tax ⓘ	0	0	0	0	0	0	0	0	0	1
Profit After Tax	-2	-15	-26	-53	-2	-2	1	5	5	6
PAT Margin (%)	-1.8%	-12.7%	-80.3%	-295.0%	-8.2%	-10.4%	5.7%	15.8%	12.7%	11.3%
Adjusted EPS (₹)	-4.1	-24.8	-44.5	-90.0	-3.5	-2.9	1.7	4.9	4.5	5.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	32	18	-9	-53	-47	-49	-45	-8	-3	26
Share Capital ⓘ	6	6	6	6	6	6	8	10	10	12
Reserves ⓘ	26	12	-15	-59	-53	-55	-53	-18	-13	14
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	55	61	57	45	45	45	42	3	1	1
Long Term Debt	5	12	7	4	8	8	5	3	1	1
Short Term Debt	50	49	50	41	37	37	37	0	0	0
Trade Payables	12	6	3	12	12	11	11	11	14	6
Others Liabilities ⓘ	14	9	8	21	8	9	12	12	10	11
Total Liabilities ⓘ	114	93	60	25	18	16	19	18	21	43
Fixed Assets
Gross Block	22	22	22	22	22	22	22	23	24	27
Accumulated Depreciation	8	9	11	12	13	14	14	15	16	17
Net Fixed Assetsⓘ	14	13	11	10	9	8	8	7	8	10
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	23	20	10	2	1	2	1	2	5	10
Trade Receivables	67	48	32	5	5	1	7	5	2	5
Cash Equivalents	1	0	0	0	0	0	0	0	0	10
Others Assetsⓘ	10	12	7	7	3	5	4	4	6	9
Total Assets ⓘ	114	93	60	25	18	16	19	18	21	43

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	-1	0	10	3	2	0	1	9	5	-11
PBT ⓘ	-3	-15	-17	-53	-2	-2	1	5	5	8
Adjustment ⓘ	8	9	6	2	1	2	1	-1	1	1
Changes in Working Capital ⓘ	-7	6	21	55	3	0	-2	4	-1	-18
Tax Paid ⓘ	0	0	0	0	0	0	0	0	0	-1
Cash Flow From Investing Activity ⓘ	9	-1	0	0	0	0	0	-1	-1	-12
Capex	9	-1	0	0	0	0	0	-1	-1	-3
Net Investments	0	0	0	0	0	0	0	0	0	-9
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Financing Activityⓘ	-7	-1	-10	-3	-2	0	0	-8	-4	23
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	3	2	0	25
Net Proceeds from Borrowing ⓘ	-1	8	-5	-3	4	1	0	0	0	0
Interest Paid ⓘ	-8	-8	-5	0	0	-1	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	1	0	0	0	-6	0	-3	-9	-3	-2
Net Cash Flow ⓘ	0	-1	0	0	0	0	0	0	0	0

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	-7.19	-58.98	N/A	N/A	N/A	N/A	N/A	N/A	N/A	54.08
ROCE (%)	5.69	-7.28	N/A	N/A	N/A	N/A	N/A	N/A	N/A	55.32
Asset Turnover Ratio	1.15	1.12	0.43	0.42	1.17	0.97	1.47	1.66	1.81	1.77
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	N/A	1	1.8	1	-1.83
Working Capital Days
Receivable Days	181	182	446	378	76	70	55	68	35	21
Inventory Days	60	68	168	124	21	25	18	16	36	48
Payable Days	47	30	60	108	289	461	264	327	247	125

Sanjivani Paranteral Ltd Stock News

Sanjivani Paranteral Ltd FAQs

What is the share price of Sanjivani Paranteral?

Company share prices are keep on changing according to the market conditions. The closing price of Sanjivani Paranteral on 17-Jun-2025 16:59 is ₹230.4.

What is the market cap of Sanjivani Paranteral?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 17-Jun-2025 16:59 the market cap of Sanjivani Paranteral stood at ₹271.6.

What is the P/E ratio of Sanjivani Paranteral?

The latest P/E ratio of Sanjivani Paranteral as of 17-Jun-2025 16:59 is 33.53.

What is the P/B ratio of Sanjivani Paranteral?

The latest P/B ratio of Sanjivani Paranteral as of 17-Jun-2025 16:59 is 7.11.

What is the 52-week high and low of Sanjivani Paranteral?

The 52-week high of Sanjivani Paranteral is ₹396.9 and the 52-week low is ₹171.5.

What is the TTM revenue of Sanjivani Paranteral?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sanjivani Paranteral is ₹70.10 ( Cr.) .

About Sanjivani Paranteral Ltd

Sanjivani Parenteral was established in 1997 by A H Khemka, Ashwin Khemka and Somesh Khemka, under the technical direction of Mahendra Kalwankar. It is a research-based, international pharmaceutical company that provides a wide range of high quality products and services at affordable prices. The core product range of the companyâ€™s products includes oral solids, small volume parenterals and sterile powder formulations.

The company has grown many folds and aspires to be a respected research-based company. With its diverse product portfolio, it is rapidly expanding its reach to the global marketplace, riding on its success in India and in the worldâ€™s emerging and developed markets.

After establishing itself in India, Sanjivani has extended its reach globally by entering the markets of Asia, Europe, Africa and Latin America. The company has active presence in countries like Russia, Ukraine, Uzbekistan, Turkmenistan, Fiji, Vietnam, Sri Lanka, Nepal, Malaysia, Thailand, Nigeria and Peru, to name a few. Sanjivani Parenteral has also got its plant approved by the registration authorities of Congo, Sudan and Sri Lanka. It is making its presence felt in the world market now, through leveraging its manufacturing capacity, quality of products and international alliances.

International business contributes about 30% of the companyâ€™s revenue and is set to grow to more than 50% in the coming two years. This includes the sales of Sanjivaniâ€™s own brands and the revenue from the contract manufacturing services that the company provides to its overseas clients. The company is in the making of a strong base to broaden its horizons.

Sanjivani has been a regular supplier to the armed forcesâ€™ hospitals in India. Furthermore, many government and private hospitals have availed of the products and services offered by Sanjivani across the country. The company also has its own marketing operations in India and boasts of over 1000 distributors all over India.

Products

Therapeutic Products
Animal Products
Key Products
Oral Solids

SEBI Registered: Investment Adviser - INA000013323 RIA Details

Warning: Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Disclaimer: Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provides any assurance of returns to investors.

Compliance Officer:

Name: Shrikant Jagtap

Email: shrikant.jagtap@moneyworks4me.com

Mobile No: +91 97638 00745

Grievance Officer:

Name: Mukta Vaze

Email: mukta.vaze@moneyworks4me.com

Mobile No:+91 98609 19463

Principal Officer:

Name: Atharva Bhide

Email: atharva.bhide@moneyworks4me.com

Mobile No:+91 91758 99463

SEBI regional/local office address-

Plot No. C 4-A , G Block, Near Bank of India, Bandra Kurla Complex, Bandra East, Mumbai, Maharashtra 400051

Address:

The Alchemists Ark Pvt. Ltd., B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Data provided by Accord Fintech Pvt. Ltd.

Please wait your portfolio is updating...

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity - May 16, 2019 - Perpetual
BASL Membership ID:	BASL1187
Address	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Sanjivani Paranteral Ltd - Stock Valuation and Financial Performance

Sanjivani Paranteral Share Price

DeciZen - make an informed investing decision on Sanjivani Paranteral Share

Overall Rating ⓘ M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation ⓘ

3. Price Trend

Sanjivani Paranteral stock performance -

Is Sanjivani Paranteral Ltd an attractive stock to invest in?

1. Is Sanjivani Paranteral Ltd a good quality company?

2. Is Sanjivani Paranteral Ltd undervalued or overvalued?

3. Is Sanjivani Paranteral Ltd a good buy now?

10 Year X-Ray of Sanjivani Paranteral: Share

Analysis of Financial Track Record

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Recent Performance Summary

Latest Financials - Sanjivani Paranteral Ltd.

Management X-Ray of Sanjivani Paranteral: Share

Shareholding Pattern

Promoter's Holding & Share Pledging